Ken Kramer, PhD

Vice President, Head of Global Medical Neuroscience
Bristol Myers Squibb

Poster(s):

• (379) Antipsychotic medication utilization and treatment patterns among patients with schizophrenia: A real-world evidence study
  Wednesday, October 29, 2025